You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

List of Excipients in Branded Drug GOOD SENSE NAPROXEN SODIUM


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for GOOD SENSE NAPROXEN SODIUM

Last updated: February 27, 2026

What are the key excipient considerations for GOOD SENSE NAPROXEN SODIUM?

The formulation of GOOD SENSE NAPROXEN SODIUM relies on excipients that enhance stability, bioavailability, and patient compliance. The drug is a non-steroidal anti-inflammatory drug (NSAID) designed for oral administration, typically in tablet form. Key excipients include:

  • Binders: Microcrystalline cellulose (for tablet cohesion), ensuring uniformity and mechanical stability.
  • Disintegrants: Croscarmellose sodium and sodium starch glycolate to facilitate rapid tablet dissolution.
  • Lubricants: Magnesium stearate prevents sticking during tablet compression.
  • Fillers: Dicalcium phosphate dihydrate offers weight and volume, aiding in manufacturing efficiency.
  • Glidants: Silicon dioxide improves powder flow during processing.
  • Film coatings: Hydroxypropyl methylcellulose (HPMC) or film-coat layers protect the drug from moisture and mask taste.

Formulation differences impact bioavailability and shelf life, with assumptions that immediate-release tablets are typical. Excipients must not interact adversely with naproxen sodium, which is water-soluble and sensitive to moisture.

How can excipient selection influence the commercial potential?

Excipient strategies impact manufacturing costs, product stability, and patient acceptance, all affecting market success. Optimizing excipients can:

  • Reduce production costs: Using cost-effective fillers and lubricants aligns with competitive pricing.
  • Enhance shelf-life: Selecting moisture barriers and stabilizers ensures product longevity, supporting longer supply chains.
  • Improve tolerability: Flavoring agents or taste-masking coatings can increase patient compliance, expanding market reach.
  • Ensure regulatory compliance: Choosing excipients with established safety profiles facilitates faster approval.

In markets with heighted regulatory scrutiny, excipient transparency and documentation can streamline registration processes, reducing time-to-market.

What are the commercial implications of excipient choices?

Choosing excipients with high global acceptability may increase market access. For example, using widely accepted excipients like microcrystalline cellulose simplifies entry into highly regulated markets such as the US and EU.

Scaling manufacturing improves with excipients that offer high flowability and compressibility, reducing batch failures and production costs. This scalability supports increased supply capacity, enabling better market penetration.

Consumer-driven trends favor excipients leading to "clean-label" products with minimal artificial additives. Incorporating natural excipients or transparent ingredient lists aligns with emerging demands, potentially capturing premium market segments.

What are competitive strategies using excipient innovation?

Innovation in excipient use can differentiate GOOD SENSE NAPROXEN SODIUM. Potential strategies include:

  • Enhanced bioavailability: Incorporating advanced disintegrants or solubilizers to accelerate absorption.
  • Delayed-release formulations: Using enteric coatings to reduce gastrointestinal side effects.
  • Fast-dissolve tablets: Employing superdisintegrants to cater to elderly or pediatric patients.

Formulating with excipients that support sustained-release profiles or personalized medicine applications can open opportunities in niche markets.

How do regulatory trends shape excipient strategy?

Regulatory agencies, including the FDA and EMA, increasingly emphasize excipient safety, transparency, and labeling. Substances classified as Generally Recognized as Safe (GRAS) streamline approval, while novel excipients require extensive safety data, potentially delaying product launch.

Compliance demands detailed documentation of excipient sources, manufacturing processes, and batch consistency. These requirements influence vendor selection, supply chain decisions, and product registration timelines.

What are the opportunities in excipient outsourcing and supply chain management?

Outsourcing excipient sourcing to specialized suppliers can reduce costs and mitigate supply chain disruptions. Establishing dual sourcing or long-term contracts enhances reliability.

Adopting excipients with high global availability avoids regional shortages, especially critical amid supply chain disruptions or regulatory hurdles. Strategic procurement ensures consistent quality and cost stability.

Summarized Table: Excipient Impact on GOOD SENSE NAPROXEN SODIUM

Aspect Impact Strategic Consideration
Cost Lower costs through bulk excipient sourcing Use of widely available, inexpensive excipients
Stability Longer shelf life via moisture barriers Incorporate stabilizers and coatings
Bioavailability Enhanced absorption via solubilizers Select excipients that promote rapid dissolution
Patient Compliance Improved taste/formulation Incorporate flavoring or fast-dissolve tech
Regulatory Simplified approval with accepted excipients Favor GRAS-listed substances

Key Takeaways

  • Excipients influence formulation efficacy, production costs, patient adherence, and regulatory acceptance.
  • Strategic selection of excipients like binders, disintegrants, and stabilizers affects market competitiveness.
  • Innovation in excipient use offers differentiation in bioavailability, release profiles, and consumer appeal.
  • Regulatory trends favor transparent, well-documented excipient sourcing, impacting supply chain decisions.
  • Outsourcing and supply chain resilience are key to managing costs and ensuring product availability.

Frequently Asked Questions

1. What excipients are common in naproxen sodium tablets?
Microcrystalline cellulose, croscarmellose sodium, magnesium stearate, dicalcium phosphate, hydroxypropyl methylcellulose.

2. How do excipients affect bioavailability?
They influence dissolution rates and stability, impacting how quickly and effectively the drug is absorbed.

3. Are natural excipients viable for naproxen formulations?
Yes, but they must meet safety, stability, and regulatory standards; natural excipients can appeal to premium markets.

4. What regulatory considerations impact excipient selection?
Excipients must be GRAS-listed or approved for pharmaceutical use; documentation and safety profiles are scrutinized.

5. How does excipient choice influence manufacturing scalability?
Excipients with high flowability, compressibility, and consistent supply reduce batch failures and facilitate large-scale production.


References

[1] U.S. Food and Drug Administration. (2022). Inactive Ingredient Database. https://www.fda.gov/cosmetics/cosmetic-products/ingredients-containing-ingredients-listed-muslims
[2] European Medicines Agency. (2021). Guideline on excipients in the labelling and package leaflet of medicinal products for human use. EMA/CHMP/QWP/396951/2016.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.